GenNext® Technologies is collaborating with Thermo Fisher Scientific to improve biotherapeutic development. The organizations are combining GenNext’s AutoFox® Protein Footprinting System with Thermo Fisher’s liquid chromatography-mass spectrometry (LC-MS) solutions, particularly Thermo Scientific™ Orbitrap™ instrumentation, sample preparation technology and other structural proteomics consumables, such as crosslinkers and fluorescence labels, to create a powerful, end-to-end workflow solution for researchers working on complex protein structure and drug interaction studies.
The integrated workflow delivers high-resolution insights into protein structure and dynamics—essential for optimizing drug safety, efficacy and delivery. It also offers researchers a valuable toolset to help validate structural models generated by artificial intelligence (AI), an emerging frontier in drug discovery.
“We’re thrilled to collaborate with Thermo Fisher Scientific in advancing the boundaries of structural biology,” said Scot Weinberger, CEO, GenNext Technologies. “By integrating our Fox® product line with Thermo Fisher’s MS instrumentation such as Thermo Scientific™ Orbitrap™ Tribrid™ MS or Thermo Scientific™ Orbitrap Exploris™ MS, advanced reagents and data processing software, researchers can rapidly gain unprecedented visibility into biomolecular structure and behavior with unprecedented speed and simplicity.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!